1. Home
  2. STVN vs FRHC Comparison

STVN vs FRHC Comparison

Compare STVN & FRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • FRHC
  • Stock Information
  • Founded
  • STVN 1949
  • FRHC 1981
  • Country
  • STVN Italy
  • FRHC Kazakhstan
  • Employees
  • STVN N/A
  • FRHC N/A
  • Industry
  • STVN Containers/Packaging
  • FRHC Investment Bankers/Brokers/Service
  • Sector
  • STVN Consumer Discretionary
  • FRHC Finance
  • Exchange
  • STVN Nasdaq
  • FRHC Nasdaq
  • Market Cap
  • STVN 6.2B
  • FRHC 7.2B
  • IPO Year
  • STVN 2021
  • FRHC N/A
  • Fundamental
  • Price
  • STVN $22.88
  • FRHC $134.63
  • Analyst Decision
  • STVN Buy
  • FRHC
  • Analyst Count
  • STVN 6
  • FRHC 0
  • Target Price
  • STVN $27.50
  • FRHC N/A
  • AVG Volume (30 Days)
  • STVN 373.4K
  • FRHC 81.1K
  • Earning Date
  • STVN 03-06-2025
  • FRHC 02-07-2025
  • Dividend Yield
  • STVN 0.25%
  • FRHC N/A
  • EPS Growth
  • STVN N/A
  • FRHC 11.75
  • EPS
  • STVN 0.48
  • FRHC 5.68
  • Revenue
  • STVN $1,220,254,294.00
  • FRHC $1,306,629,000.00
  • Revenue This Year
  • STVN $3.01
  • FRHC N/A
  • Revenue Next Year
  • STVN $7.07
  • FRHC N/A
  • P/E Ratio
  • STVN $48.10
  • FRHC $23.70
  • Revenue Growth
  • STVN 3.53
  • FRHC 68.86
  • 52 Week Low
  • STVN $16.56
  • FRHC $64.00
  • 52 Week High
  • STVN $34.73
  • FRHC $136.02
  • Technical
  • Relative Strength Index (RSI)
  • STVN 56.08
  • FRHC 60.64
  • Support Level
  • STVN $21.42
  • FRHC $121.74
  • Resistance Level
  • STVN $24.38
  • FRHC $133.60
  • Average True Range (ATR)
  • STVN 1.24
  • FRHC 3.71
  • MACD
  • STVN -0.08
  • FRHC -0.27
  • Stochastic Oscillator
  • STVN 59.95
  • FRHC 90.27

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About FRHC Freedom Holding Corp.

Freedom Holding Corp is a holding company with its subsidiary it is engaged in securities brokerage, securities dealing for customers and account, market-making activities, investment research, investment counseling, investment banking services, retail and commercial banking, insurance products, payment services, and information processing services. It acts as a professional participant through its subsidiaries on the Kazakhstan Stock Exchange (KASE), Moscow Exchange (MOEX), Saint-Petersburg Exchange (SPB), the Ukrainian Exchange, the Uzbek Republican Currency Exchange (UZCE), and the Republican Stock Exchange of Tashkent (UZSE). Its segments are Brokerage, Banking, Insurance, and Others.

Share on Social Networks: